Dalfopristin and quinupristin and Rucaparib Camsylate
Determining the interaction of Dalfopristin and quinupristin and Rucaparib Camsylate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Dalfopristin may increase the blood levels and effects of rucaparib. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration with potent inhibitors of CYP450 3A4 may increase the plasma concentrations and the risk of adverse effects of rucaparib, which has been shown in vitro to be a substrate of the isoenzyme. However, the effects on the pharmacokinetics of rucaparib have not been evaluated in vivo.
MANAGEMENT: Caution is advised if rucaparib is used concomitantly with potent CYP450 3A4 inhibitors. Dosage adjustments as well as clinical and laboratory monitoring should be considered whenever a potent CYP450 3A4 inhibitor is added to or withdrawn from therapy with rucaparib.
- EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring. Available from: URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000366.jsp&mid=WC0b01ac058067c852" ([2013 - ]):
Generic Name: dalfopristin / quinupristin
Brand name: Synercid
Synonyms: Quinupristin and Dalfopristin
Generic Name: rucaparib
Brand name: Rubraca
Synonyms: Rucaparib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dalfopristin and quinupristin-Ruconest
- Dalfopristin and quinupristin-Rufinamide
- Dalfopristin and quinupristin-Rufinamide Oral Suspension
- Dalfopristin and quinupristin-Rufinamide Tablets
- Dalfopristin and quinupristin-Rulox
- Dalfopristin and quinupristin-Rum-K
- Rucaparib Camsylate-Daliresp
- Rucaparib Camsylate-Dallergy
- Rucaparib Camsylate-Dallergy (Dexbrompheniramine and Phenylephrine Syrup)
- Rucaparib Camsylate-Dallergy (Dexbrompheniramine and Phenylephrine Tablets)
- Rucaparib Camsylate-Dallergy Chewable Tablets
- Rucaparib Camsylate-Dallergy Drops